NPI: 1841299039 · ELYRIA, OH 44035 · General Acute Care Hospital · NPI assigned 07/19/2005
Authorized official SCHILLERO, ANTHONY controls 20+ related entities in our dataset. Read more
| Authorized Official | SCHILLERO, ANTHONY (DIRECTOR, FP&A) |
| NPI Enumeration Date | 07/19/2005 |
Other providers sharing the same authorized official: SCHILLERO, ANTHONY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 151,916 | $5.29M |
| 2019 | 111,871 | $4.24M |
| 2020 | 75,654 | $4.38M |
| 2021 | 83,693 | $4.32M |
| 2022 | 84,627 | $4.33M |
| 2023 | 282,972 | $11.40M |
| 2024 | 209,233 | $7.51M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 71,111 | 67,094 | $8.27M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 37,894 | 34,497 | $5.05M |
| 96361 | Intravenous infusion, hydration; each additional hour | 13,859 | 11,606 | $4.32M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 27,110 | 23,788 | $3.47M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15,740 | 14,343 | $2.13M |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 18,107 | 15,605 | $1.87M |
| 70450 | Computed tomography, head or brain; without contrast material | 6,544 | 5,504 | $1.63M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 19,056 | 6,865 | $1.38M |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 9,291 | 8,512 | $1.27M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5,522 | 4,522 | $1.27M |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 4,804 | 3,227 | $708K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2,243 | 1,879 | $580K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1,812 | 1,414 | $470K |
| 20610 | 3,376 | 2,487 | $459K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 3,664 | 1,712 | $398K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 4,309 | 2,300 | $393K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1,603 | 1,437 | $390K |
| 80053 | Comprehensive metabolic panel | 45,659 | 39,719 | $360K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1,628 | 986 | $354K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3,176 | 2,966 | $353K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1,742 | 1,400 | $336K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 2,985 | 1,040 | $249K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 602 | 531 | $222K |
| 11043 | 842 | 419 | $195K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 1,136 | 977 | $190K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 295 | 282 | $188K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1,619 | 1,548 | $174K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1,329 | 1,254 | $162K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 734 | 693 | $162K |
| G0378 | Hospital observation service, per hour | 2,928 | 1,377 | $160K |
| 11045 | 661 | 237 | $152K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 5,990 | 4,957 | $118K |
| 80048 | Basic metabolic panel (calcium, ionized) | 15,438 | 12,843 | $112K |
| 71046 | Radiologic examination, chest; 2 views | 11,050 | 10,269 | $105K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 9,353 | 8,063 | $100K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 4,679 | 1,906 | $96K |
| 73610 | 3,684 | 3,131 | $89K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 31,139 | 24,519 | $89K |
| 76770 | 524 | 487 | $83K | |
| 97161 | 2,001 | 1,694 | $79K | |
| 93017 | 932 | 827 | $77K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 5,010 | 4,239 | $73K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 799 | 656 | $70K |
| 73110 | 2,828 | 2,312 | $69K | |
| 73630 | 3,705 | 3,212 | $68K | |
| 95886 | 244 | 216 | $67K | |
| 97113 | 880 | 331 | $66K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 804 | 694 | $64K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2,669 | 2,510 | $60K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 2,029 | 1,739 | $60K |
| 20526 | 301 | 259 | $57K | |
| 73140 | 1,998 | 1,570 | $56K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 1,262 | 1,143 | $53K |
| 20611 | 228 | 178 | $53K | |
| 87631 | 572 | 562 | $52K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 501 | 390 | $52K |
| 84484 | 21,651 | 12,915 | $52K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 61,096 | 53,325 | $50K |
| 73130 | 2,638 | 2,161 | $50K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2,667 | 2,509 | $49K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 187 | 156 | $47K |
| 70491 | 162 | 126 | $47K | |
| 73564 | 2,200 | 1,879 | $47K | |
| 71250 | 597 | 524 | $46K | |
| 12001 | 290 | 257 | $45K | |
| 93971 | 719 | 605 | $45K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 280 | 260 | $42K |
| 71045 | Radiologic examination, chest; single view | 14,805 | 12,726 | $41K |
| 73030 | 2,076 | 1,724 | $40K | |
| 97165 | 834 | 654 | $38K | |
| 83605 | 13,252 | 9,821 | $37K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1,722 | 1,631 | $35K |
| 72110 | 763 | 698 | $35K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 10,140 | 9,122 | $33K |
| 86850 | 1,718 | 1,442 | $33K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1,169 | 1,083 | $32K |
| 82607 | 1,246 | 1,179 | $31K | |
| 80320 | 1,748 | 1,530 | $31K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 247 | 216 | $31K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 10,044 | 9,375 | $29K |
| 72131 | 543 | 444 | $29K | |
| 25600 | 104 | 99 | $29K | |
| 76536 | 272 | 247 | $29K | |
| 73560 | 1,096 | 867 | $28K | |
| 76642 | 239 | 206 | $27K | |
| 70486 | 596 | 523 | $27K | |
| 36415 | Collection of venous blood by venipuncture | 25,273 | 18,360 | $26K |
| 84443 | Thyroid stimulating hormone (TSH) | 2,715 | 2,439 | $26K |
| 93970 | 225 | 200 | $25K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 28,266 | 24,764 | $25K |
| 93458 | 27 | 25 | $24K | |
| 76830 | Ultrasound, transvaginal | 997 | 850 | $24K |
| 82805 | 822 | 608 | $24K | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 1,579 | 1,337 | $24K |
| 99215 | Prolong outpt/office vis | 285 | 260 | $24K |
| 93880 | 297 | 272 | $24K | |
| 73562 | 838 | 701 | $23K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 1,952 | 1,600 | $23K |
| 83880 | 4,666 | 3,862 | $22K | |
| 73502 | 1,082 | 934 | $22K | |
| 70496 | 100 | 69 | $22K | |
| 80061 | Lipid panel | 2,028 | 1,890 | $22K |
| 86900 | 1,881 | 1,569 | $21K | |
| 93975 | 145 | 120 | $21K | |
| 73221 | 119 | 110 | $21K | |
| 97162 | 574 | 497 | $21K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 74 | 57 | $19K |
| 74018 | 468 | 408 | $19K | |
| 73080 | 806 | 650 | $19K | |
| 20550 | 125 | 94 | $18K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 943 | 446 | $18K |
| 85027 | 4,396 | 2,990 | $18K | |
| 72100 | 672 | 597 | $18K | |
| 87040 | 2,281 | 1,279 | $17K | |
| 96367 | 453 | 332 | $17K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1,261 | 1,144 | $14K |
| 93296 | 783 | 738 | $13K | |
| 64721 | 14 | 14 | $13K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 20,469 | 16,935 | $13K |
| 27786 | 42 | 37 | $13K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 32 | 24 | $12K |
| 29075 | 89 | 78 | $12K | |
| 87510 | 724 | 686 | $11K | |
| 74174 | 271 | 195 | $11K | |
| 90715 | 754 | 606 | $11K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 376 | 230 | $11K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 9,636 | 8,997 | $11K |
| 73590 | 643 | 496 | $10K | |
| 82947 | 6,862 | 2,345 | $10K | |
| 81001 | 20,841 | 18,859 | $10K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1,241 | 1,046 | $10K |
| 81003 | 17,982 | 16,560 | $9K | |
| 72050 | 203 | 181 | $9K | |
| 95910 | 87 | 84 | $9K | |
| 87660 | 713 | 675 | $9K | |
| 87480 | 724 | 686 | $9K | |
| 74019 | 141 | 124 | $8K | |
| 83735 | 8,723 | 6,690 | $8K | |
| 85610 | 11,132 | 9,429 | $8K | |
| 85379 | 2,476 | 2,063 | $8K | |
| 86780 | 323 | 290 | $8K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 11,674 | 9,793 | $8K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1,009 | 531 | $7K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2,291 | 2,218 | $7K |
| 73700 | 61 | 55 | $7K | |
| 84702 | 4,551 | 3,699 | $7K | |
| 96376 | 2,822 | 1,595 | $7K | |
| 87205 | 1,486 | 1,271 | $7K | |
| 73090 | 410 | 329 | $7K | |
| 86901 | 1,890 | 1,569 | $7K | |
| 87800 | 564 | 497 | $6K | |
| 97535 | Self-care/home management training, each 15 minutes | 259 | 191 | $6K |
| 99152 | 475 | 355 | $6K | |
| 82570 | 518 | 491 | $6K | |
| 95816 | 45 | 39 | $5K | |
| 11046 | 31 | 12 | $5K | |
| 70498 | 102 | 81 | $5K | |
| 72040 | 167 | 152 | $5K | |
| 83690 | 13,413 | 11,589 | $5K | |
| J3490 | Unclassified drugs | 3,024 | 1,756 | $5K |
| 12002 | 30 | 25 | $4K | |
| 94726 | 82 | 77 | $4K | |
| 93298 | 254 | 249 | $4K | |
| 72128 | 174 | 138 | $4K | |
| 97116 | 258 | 125 | $4K | |
| 80076 | 2,202 | 1,877 | $4K | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 312 | 252 | $3K |
| 82077 | 2,731 | 2,179 | $3K | |
| 86140 | 1,363 | 1,124 | $3K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 6,571 | 6,180 | $3K |
| 82043 | 491 | 465 | $3K | |
| 84156 | 491 | 469 | $3K | |
| 97016 | 84 | 33 | $3K | |
| 10060 | 17 | 13 | $3K | |
| 95861 | 15 | 12 | $3K | |
| 20600 | 19 | 16 | $3K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 110 | 80 | $3K |
| 84439 | 224 | 205 | $3K | |
| 87081 | 1,318 | 1,271 | $3K | |
| J1815 | Injection, insulin, per 5 units | 335 | 134 | $2K |
| 84703 | 4,826 | 4,568 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 860 | 658 | $2K |
| 12011 | 15 | 14 | $2K | |
| 85730 | 4,284 | 3,692 | $2K | |
| 73552 | 123 | 109 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 8,083 | 7,696 | $2K |
| 94729 | 106 | 101 | $2K | |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 137 | 93 | $2K |
| 80143 | 2,127 | 1,671 | $2K | |
| 81025 | 5,945 | 5,320 | $2K | |
| 82550 | 2,125 | 1,566 | $2K | |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography | 12 | 12 | $2K |
| 87070 | 1,112 | 927 | $2K | |
| 87077 | 667 | 453 | $2K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 15,971 | 13,400 | $2K |
| C1889 | Implantable/insertable device, not otherwise classified | 25 | 20 | $2K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 121 | 112 | $2K |
| 76870 | 75 | 63 | $2K | |
| 87634 | 881 | 820 | $2K | |
| 72170 | 392 | 323 | $2K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 163 | 121 | $1K |
| J1170 | Injection, hydromorphone, up to 4 mg | 2,423 | 1,367 | $1K |
| 87186 | 1,076 | 805 | $1K | |
| 82150 | 2,010 | 1,871 | $1K | |
| 87340 | 102 | 98 | $1K | |
| 88142 | 97 | 97 | $1K | |
| 86803 | 90 | 86 | $1K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 5,465 | 3,922 | $1K |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 400 | 191 | $1K |
| J3535 | Drug administered through a metered dose inhaler | 201 | 139 | $1K |
| 82330 | 613 | 469 | $1K | |
| 76937 | 33 | 20 | $1K | |
| 94150 | 48 | 43 | $1K | |
| 87075 | 1,718 | 1,209 | $1K | |
| A9270 | Non-covered item or service | 8,968 | 1,529 | $1K |
| 73660 | 28 | 24 | $953.00 | |
| 73000 | 59 | 54 | $910.34 | |
| 80179 | 2,084 | 1,655 | $882.76 | |
| 99153 | Mod sedat endo service >5yrs | 152 | 102 | $877.28 |
| 85007 | 119 | 66 | $823.47 | |
| 93922 | 12 | 12 | $780.88 | |
| 94200 | 34 | 31 | $775.73 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 1,055 | 454 | $742.72 |
| J3300 | Injection, triamcinolone acetonide, preservative free, 1 mg | 40 | 38 | $734.47 |
| C9113 | Injection, pantoprazole sodium, per vial | 915 | 573 | $695.01 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 5,023 | 3,629 | $626.85 |
| 84132 | 1,026 | 771 | $607.41 | |
| 83970 | 18 | 13 | $578.82 | |
| 86762 | 30 | 26 | $575.86 | |
| 82746 | 41 | 25 | $554.67 | |
| 88300 | 12 | 12 | $531.91 | |
| 73060 | 87 | 68 | $522.18 | |
| 83655 | 14 | 14 | $513.63 | |
| 77066 | Tomosynthesis, mammo | 47 | 42 | $512.86 |
| 82728 | 38 | 26 | $480.50 | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 252 | 222 | $477.97 |
| 84100 | 612 | 479 | $471.30 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 11,259 | 9,329 | $466.89 |
| 85018 | 620 | 475 | $443.69 | |
| 86141 | 996 | 931 | $433.08 | |
| 86787 | 41 | 37 | $430.55 | |
| 72120 | 113 | 99 | $429.43 | |
| 82435 | 549 | 427 | $424.51 | |
| 29125 | 91 | 81 | $404.23 | |
| 84153 | 18 | 15 | $397.60 | |
| 77062 | 13 | 13 | $391.49 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 10,365 | 8,640 | $379.36 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 1,696 | 755 | $373.55 |
| 85652 | 546 | 438 | $369.29 | |
| 93297 | 17 | 17 | $338.05 | |
| 93280 | 29 | 28 | $331.54 | |
| 82950 | 38 | 38 | $328.21 | |
| 83721 | 28 | 25 | $326.41 | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 935 | 728 | $326.22 |
| J1644 | Injection, heparin sodium, per 1000 units | 1,312 | 654 | $320.86 |
| 82248 | 1,077 | 897 | $299.08 | |
| 80069 | 21 | 14 | $294.87 | |
| 74022 | 26 | 25 | $292.77 | |
| 83540 | 45 | 31 | $287.01 | |
| 87807 | 1,111 | 1,078 | $276.56 | |
| 88112 | 12 | 12 | $271.02 | |
| 76801 | 103 | 88 | $260.72 | |
| J7328 | Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | 62 | 38 | $254.05 |
| 83550 | 37 | 26 | $247.44 | |
| 90686 | 19 | 12 | $240.34 | |
| 84295 | 551 | 429 | $237.38 | |
| 36600 | 245 | 173 | $230.05 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 1,962 | 1,606 | $228.79 |
| J3370 | Injection, vancomycin hcl, 500 mg | 436 | 242 | $209.76 |
| J7999 | Compounded drug, not otherwise classified | 285 | 211 | $204.39 |
| 93290 | 37 | 34 | $203.75 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 1,433 | 966 | $191.66 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 14,564 | 11,501 | $180.36 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 1,494 | 1,093 | $153.65 |
| 82010 | 243 | 171 | $149.93 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 2,351 | 1,710 | $134.58 |
| G0404 | Electrocardiogram, routine ecg with 12 leads; tracing only, without interpretation and report, performed as a screening for the initial preventive physical examination | 147 | 102 | $130.22 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 4,047 | 2,834 | $113.41 |
| 80329 | 180 | 83 | $109.83 | |
| 0753T | 72 | 47 | $109.47 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 247 | 199 | $105.85 |
| J2704 | Injection, propofol, 10 mg | 3,551 | 2,582 | $105.58 |
| 29515 | 13 | 12 | $100.43 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 335 | 251 | $98.19 |
| J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg | 1,148 | 758 | $89.07 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 403 | 352 | $85.01 |
| J7070 | Infusion, d5w, 1000 cc | 124 | 52 | $80.67 |
| 82948 | 201 | 171 | $62.41 | |
| J8540 | Dexamethasone, oral, 0.25 mg | 761 | 421 | $58.71 |
| 84550 | 34 | 29 | $57.84 | |
| A4217 | Sterile water/saline, 500 ml | 920 | 567 | $57.49 |
| J2060 | Injection, lorazepam, 2 mg | 406 | 307 | $55.65 |
| 94762 | 26 | 19 | $53.94 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 2,138 | 1,895 | $53.77 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 503 | 392 | $53.70 |
| 73100 | 154 | 115 | $52.76 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 1,346 | 1,088 | $52.00 |
| 94761 | 1,278 | 1,051 | $51.99 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 3,013 | 2,171 | $51.83 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 174 | 150 | $50.71 |
| J3480 | Injection, potassium chloride, per 2 meq | 452 | 269 | $49.96 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 1,065 | 793 | $49.03 |
| J1630 | Injection, haloperidol, up to 5 mg | 200 | 120 | $41.74 |
| 72114 | 38 | 38 | $40.31 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 3,144 | 2,266 | $35.50 |
| J0690 | Injection, cefazolin sodium, 500 mg | 509 | 358 | $33.73 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 1,032 | 737 | $33.11 |
| C1769 | Guide wire | 232 | 181 | $29.16 |
| J7050 | Infusion, normal saline solution, 250 cc | 906 | 591 | $25.97 |
| 86308 | 76 | 64 | $25.74 | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 485 | 285 | $22.89 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 69 | 39 | $21.74 |
| J1171 | Injection, hydromorphone, 0.1 mg | 181 | 118 | $19.00 |
| 81002 | 20 | 16 | $12.39 | |
| J0744 | Injection, ciprofloxacin for intravenous infusion, 200 mg | 29 | 12 | $11.58 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 29 | 27 | $11.18 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 500 | 323 | $10.95 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 123 | 102 | $10.78 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 490 | 348 | $8.21 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 143 | 104 | $6.79 |
| 76377 | 833 | 722 | $5.27 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 143 | 106 | $4.96 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 50 | 41 | $4.00 |
| J1920 | Injection, labetalol hydrochloride, 5 mg | 37 | 26 | $3.98 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 96 | 77 | $2.50 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 33 | 24 | $2.34 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 183 | 130 | $0.48 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 316 | 303 | $0.32 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 158 | 104 | $0.00 |
| 82803 | 43 | 41 | $0.00 | |
| J2785 | Injection, regadenoson, 0.1 mg | 271 | 245 | $0.00 |
| 94760 | 292 | 178 | $0.00 | |
| A9698 | Non-radioactive contrast imaging material, not otherwise classified, per study | 56 | 24 | $0.00 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 12 | 12 | $0.00 |
| G0269 | Placement of occlusive device into either a venous or arterial access site, post surgical or interventional procedure (e.g., angioseal plug, vascular plug) | 23 | 12 | $0.00 |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 611 | 490 | $0.00 |
| 87185 | 14 | 12 | $0.00 | |
| 01810 | 13 | 13 | $0.00 | |
| 94664 | 42 | 40 | $0.00 | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 41 | 36 | $0.00 |
| 00840 | 179 | 105 | $0.00 | |
| 00811 | 37 | 26 | $0.00 | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 64 | 54 | $0.00 |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | 18 | 13 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 54 | 54 | $0.00 |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 12 | 12 | $0.00 |
| C1760 | Closure device, vascular (implantable/insertable) | 13 | 12 | $0.00 |